Regulatory Briefs: Open Data Website Launch; Upcoming FDA Meetings
This article was originally published in The Gray Sheet
Executive Summary
FDA launches openFDA website to provide access to datasets. Agency announces upcoming Ophthalmic Devices and Risk Communications meetings. More regulatory briefs.
You may also be interested in...
FDA Questions Missing Data, Sizing Method For Visian Astigmatism-Correcting Intraocular Lens
FDA is asking its Ophthalmic Devices Panel to consider the implications of missing data and issues with sizing methodology issues tied to Staar Surgical’s PMA submission for its Visian toric implantable collamer lens to correct myopic astigmatism in adults ages 21 to 45. The panel was scheduled for Feb. 14, but it has been postponed due to weather.
Moderna Files COVID-19 Vaccine After Second Impressive Read-Out
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
Sanofi's Dupixent Cleared For Children With Atopic Dermatitis In EU
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: